{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:33:07Z","timestamp":1778841187530,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,6,27]],"date-time":"2010-06-27T00:00:00Z","timestamp":1277596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00417-010-1430-x","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T08:42:37Z","timestamp":1277541757000},"page":"1713-1718","source":"Crossref","is-referenced-by-count":52,"title":["Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage"],"prefix":"10.1007","volume":"248","author":[{"given":"Hossein","family":"Nazari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Modarres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mehdi","family":"Parvaresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Ghasemi Falavarjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,27]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","unstructured":"Early Treatment for Retinopathy of Prematurity Cooperative Group (2003) Revised indications for the treatment of retinopathy of prematurity. Results of The Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch Ophthalmol 121:1684\u20131696","journal-title":"Arch Ophthalmol"},{"key":"1430_CR2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajo.2006.05.048","volume":"142","author":"N Azuma","year":"2006","unstructured":"Azuma N, Ishikawa K, Hama Y, Hiraoka M, Suzuki Y, Nishina S (2006) Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol 142:636\u2013643","journal-title":"Am J Ophthalmol"},{"key":"1430_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/112067210701700516","volume":"17","author":"T Micelli Ferrari","year":"2007","unstructured":"Micelli Ferrari T, Furino C, Lorusso VV, Dammacco R, Sborgia G, Sborgia L, Besozzi G (2007) Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: early surgery before tractional retinal detachment appearance. Eur J Ophthalmol 17:785\u2013789","journal-title":"Eur J Ophthalmol"},{"key":"1430_CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0002-9394(03)00190-9","volume":"136","author":"KA Hutcheson","year":"2003","unstructured":"Hutcheson KA, Nquyen ATQ, Reslan MW, Ellish NJ, Steidl SM (2003) Vitreous hemorrhage in patients with high-risk retinopathy of prematurity. Am J Ophthalmol 136:258\u2013263","journal-title":"Am J Ophthalmol"},{"key":"1430_CR5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/IAE.0b013e31817f2f15","volume":"28","author":"MJ Kim","year":"2008","unstructured":"Kim MJ, Kim S, Yu YS (2008) The risk for retinal detachment associated with hemorrhages pre and postlaser treatment in retinopathy of prematurity. Retina 28:1451\u20131457","journal-title":"Retina"},{"key":"1430_CR6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajo.2007.10.027","volume":"145","author":"A Vinekar","year":"2008","unstructured":"Vinekar A, Trese MT, Capone A Jr, Photographic Screening for Retinopathy of Prematurity (PHOTO-ROP) Cooperative Group (2008) Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol 145:548\u2013555","journal-title":"Am J Ophthalmol"},{"key":"1430_CR7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","volume":"115","author":"K Sonmez","year":"2008","unstructured":"Sonmez K, Drenser KA, Capone A Jr, Trese MT (2008) Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology 115:1065\u20131070","journal-title":"Ophthalmology"},{"key":"1430_CR8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)65004-3","volume":"156","author":"K Lashkari","year":"2000","unstructured":"Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N (2000) Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol 156:1337\u20131344","journal-title":"Am J Pathol"},{"key":"1430_CR9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.iae.0000225766.75009.3a","volume":"26","author":"RM Rich","year":"2006","unstructured":"Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G (2006) Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26:495\u2013511","journal-title":"Retina"},{"key":"1430_CR10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2006.12.037","volume":"143","author":"SA Pai","year":"2007","unstructured":"Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK, Babu RB, Narayana KM (2007) Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 143:601\u2013606","journal-title":"Am J Ophthalmol"},{"key":"1430_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF, Fisher YL (2006) Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275\u2013278","journal-title":"Retina"},{"key":"1430_CR12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","volume":"28","author":"HA Mintz-Hittner","year":"2008","unstructured":"Mintz-Hittner HA, Kuffel RR (2008) Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28:831\u2013838","journal-title":"Retina"},{"key":"1430_CR13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","volume":"28","author":"H Quiroz-Mercado","year":"2008","unstructured":"Quiroz-Mercado H, Martinez-Castellanos MA, Hermamdez-Rojas ML, Salazar-Teran N, Chan RV (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28:S19\u2013S25","journal-title":"Retina"},{"key":"1430_CR14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","volume":"245","author":"EJ Chung","year":"2007","unstructured":"Chung EJ, Kim JH, Ahn HS, Koh HJ (2007) Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 245:1727\u20131730","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1430_CR15","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","volume":"28","author":"GA Lalwani","year":"2008","unstructured":"Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D, Johnson RA, Puliafito CA (2008) Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 28:S13\u2013S18","journal-title":"Retina"},{"key":"1430_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0301-4738.29505","volume":"55","author":"PK Shah","year":"2007","unstructured":"Shah PK, Narendran V, Tawansy KA, Raghuram A, Narendran K (2007) Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 55:75\u201376","journal-title":"Indian J Ophthalmol"},{"key":"1430_CR17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","volume":"92","author":"S Kusaka","year":"2008","unstructured":"Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, Fujikado T (2008) Efficacy of intravitreal injection of Bevacizumab for severe retinopathy of prematurity: A pilot study. Br J Ophthalmol 92:1450\u20131455","journal-title":"Br J Ophthalmol"},{"key":"1430_CR18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2009.05.031","volume":"148","author":"JA Micieli","year":"2009","unstructured":"Micieli JA, Surkont M, Smith AF (2009) A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity. Am J Ophthalmol 148:536\u2013543","journal-title":"Am J Ophthalmol"},{"key":"1430_CR19","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1101\/gad.322904","volume":"18","author":"Q Schwarz","year":"2004","unstructured":"Schwarz Q, Gu C, Fujisawa H, Sabelko K, Gertsenstein M, Nagy A, Taniguchi M, Kolodkin AL, Ginty DD, Shima DT, Ruhrberg C (2004) Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev 18:2822\u20132834","journal-title":"Genes Dev"},{"key":"1430_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53\u201367","journal-title":"Am J Pathol"},{"key":"1430_CR21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","volume":"126","author":"L Kong","year":"2008","unstructured":"Kong L, Mintz-Hittner HA, Penland RL, Kretzer FL, Ch\u00e9vez-Barrios P (2008) Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. Arch Ophthalmol 126:1161\u20131163","journal-title":"Arch Ophthalmol"},{"key":"1430_CR22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0b013e32832925f9","volume":"21","author":"HA Mintz-Hittner","year":"2009","unstructured":"Mintz-Hittner HA, Best LM (2009) Antivascular endothelial growth factor for retinopathy of prematurity. Curr Opin Pediatr 21:182\u2013187","journal-title":"Curr Opin Pediatr"},{"key":"1430_CR23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"An International Committee for Classification of Retinopathy of Prematurity","year":"2005","unstructured":"An International Committee for Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity. Arch Ophthalmol 123:991\u2013999","journal-title":"Arch Ophthalmol"},{"key":"1430_CR24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaapos.2009.09.018","volume":"13","author":"MM Parvaresh","year":"2009","unstructured":"Parvaresh MM, Modarres M, Falavarjani KG, Sadeghi K, Hammami P (2009) Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity. J AAPOS 13:535\u2013538","journal-title":"J AAPOS"},{"key":"1430_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J Chen","year":"2007","unstructured":"Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10:133\u2013140","journal-title":"Angiogenesis"},{"key":"1430_CR26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","volume":"124","author":"C L\u00f6fqvist","year":"2006","unstructured":"L\u00f6fqvist C, Andersson E, Sigurdsson J, Engstr\u00f6m E, H\u00e5rd AL, Niklasson A, Smith LE, Hellstr\u00f6m A (2006) Longitudinal postnatal weight and insulin-like growth factor 1 measurements in the prediction of retinopathy of prematurity. Arch Opthalmol 124:1711\u20131718","journal-title":"Arch Opthalmol"},{"key":"1430_CR27","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/01.iae.0000244285.79004.e6","volume":"26","author":"A Kychenthal","year":"2006","unstructured":"Kychenthal A, Dorta P, Katz X (2006) Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina 26:S11\u2013S15","journal-title":"Retina"},{"key":"1430_CR28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajo.2004.12.106","volume":"140","author":"DK Coats","year":"2005","unstructured":"Coats DK, Miller AM, Hussein MA, McCreery KM, Holz E, Paysse EA (2005) Involution of retinopathy of prematurity after laser treatment: factors associated with development of retinal detachment. Am J Ophthalmol 140:214\u2013222","journal-title":"Am J Ophthalmol."},{"key":"1430_CR29","first-page":"281","volume":"103","author":"DK Coats","year":"2005","unstructured":"Coats DK (2005) Retinopathy of prematurity involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical intervention. Trans Am Ophthalmol Soc 103:281\u2013312","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1430_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","volume":"92","author":"JF Arevalo","year":"2007","unstructured":"Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, Eid Farah M, Pieramici DJ, Berrocal MH, Sanchez JG (2007) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213\u2013216","journal-title":"Br J Ophthalmol"},{"key":"1430_CR31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","volume":"246","author":"S Honda","year":"2008","unstructured":"Honda S, Hirabayashi H, Tsukahara Y, Negi A (2008) Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246:1061\u20131063","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1430_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaapos.2009.06.003","volume":"13","author":"RL Avery","year":"2009","unstructured":"Avery RL (2009) Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern. J AAPOS 13:329\u2013331","journal-title":"J AAPOS"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1430-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1430-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:01Z","timestamp":1559072881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1430-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,27]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1430-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,27]]}}}